JPRN-UMIN000009370已完成未知
Thalidomide therapy clinical trial for chronic granulomatous disease-associated intractable granulomatous lesion - Thalidomide therapy for chronic granulomatous disease
ational Center for Child Heath and Development0 个研究点目标入组 5 人开始时间: 2012年11月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a pregnant woman positive for HIV severe allegy
研究者
相似试验
Unknown
2 期
Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular CancerLiver CancerNCT00006198National Center for Research Resources (NCRR)
已完成
2 期
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the UterusRecurrent Uterine Corpus SarcomaUterine Corpus LeiomyosarcomaNCT00025220National Cancer Institute (NCI)60
已完成
2 期
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell CarcinomaEndometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaNCT00025467National Cancer Institute (NCI)60
Unknown
4 期
A Study of Thalidomide in the Treatment of Refractory Uremic PruritusHaemodialysisUremic PruritusThalidomideNCT05525234RenJi Hospital40
进行中（未招募）
1 期
The use of Thalidomide as a treatment for the cachexia of incurable upper gastrointestinal adenocarcinomas:a randomised, double-blinded, placebo controlled trial. - Thalidomide in cancer cachexiaEUCTR2005-000371-18-GBPortsmouth Hospitals Trust180